% Expired Patents = 16.7

Forward Citations = 34

Loading Chart...

4 inventors (with patents filed for the assignee):

Thomas Mitts (6 out of 32 patents)

Lawrence B Sandberg (6 out of 7 patents)

Felipe Jimenez, Jr (1 out of 1 patent)

4. Philip J Roos (1 out of 2 patents)

6 patents: Sort by Forward Citations

1. 7666842 - Elastin peptide analogs and uses thereof (2010-02-23),

2. 6962904 - Elastin peptide analogs and uses thereof (2005-11-08),

3. 6809075 - Elastin peptide analogs and uses of same incombination with skin enhancing agents (2004-10-26),

4. 6794362 - Asparagine containing elastin peptide analogs (2004-09-21),

5. 6777389 - Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides (2004-08-17),

6. 6506731 - Elastin peptide analogs and methods of using same (2003-01-14),

Company Overview

Connective Tissue Imagineering, LLC is a innovative biotechnology company specializing in the development of cutting-edge solutions for connective tissue disorders. Our team of experts is dedicated to creating advanced therapies and regenerative technologies to improve the lives of patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#4 in Visalia, CA

#10,570 in California

#44,981 in US

Visalia, CA, United States of America

Connective Tissue Imagineering, LLC

Forward Citations = 34

4 inventors:

Thomas Mitts (6 out of 32 patents)

Lawrence B Sandberg (6 out of 7 patents)

Felipe Jimenez, Jr (1 out of 1 patent)

4. Philip J Roos (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Connective Tissue Imagineering, LLC. Retrieved from https://idiyas.com/company/connective-tissue-imagineering

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]